RxDoctor Payments Data

Zachary Seymour, MD

Radiation Oncology · Troy, MINPI 1164758025

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,929 of the $7,983 with a category attached, or 61.7%. Brainlab, Inc. accounts for 95.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $3,889 and has fallen 85.0% since, to $584 in 2025. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,983in general payments, 2019–2025

Across 30 payments — averaging $266.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Brainlab, Inc.$8K
  • GT Medical Technologies, Inc$178
  • Blue Earth Diagnostics$125
  • Boston Scientific$55
  • Teleflex LLC$20
$3,461in research payments, 2019–2025

Across 4 payments — averaging $865.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$3K

What the payments were for

  • Speaking & faculty fees$4,92962%
  • Travel & lodging$1,27316%
  • Food & beverage$1,78122%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,983 in reported general payments places this provider in the 90th percentile of 198 radiation oncology providers in Michigan.

See all radiation oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$146,621
Medicare patients
297
Services billed
1,590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$10,560
Tamsulosin Hcl430$8,370
Bicalutamide67$5,677
Tolterodine Tartrate18$1,144
Dexamethasone55$1,033
Tolterodine Tartrate ErTolterodine Tartrate14$833
Terazosin Hcl26$679
Doxazosin Mesylate17$307
Levetiracetam12$233
Ondansetron OdtOndansetron13$216
Gabapentin21$136
Famotidine16$76
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$72
Lorazepam14$14
Diazepam13$6

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →